[go: up one dir, main page]

EE200300442A - Meetod imidasoolühendite valmistamiseks - Google Patents

Meetod imidasoolühendite valmistamiseks

Info

Publication number
EE200300442A
EE200300442A EEP200300442A EEP200300442A EE200300442A EE 200300442 A EE200300442 A EE 200300442A EE P200300442 A EEP200300442 A EE P200300442A EE P200300442 A EEP200300442 A EE P200300442A EE 200300442 A EE200300442 A EE 200300442A
Authority
EE
Estonia
Prior art keywords
preparation
imidazole compounds
imidazole
compounds
Prior art date
Application number
EEP200300442A
Other languages
English (en)
Inventor
Ferdinand Maria Filliers Walter
Laurent Maria Broeckx Rudy
Marcel Herman Leurs Stefan
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of EE200300442A publication Critical patent/EE200300442A/et
Publication of EE05247B1 publication Critical patent/EE05247B1/et

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epoxy Resins (AREA)
EEP200300442A 2001-03-12 2002-03-05 Meetod imidasoolhendite valmistamiseks EE05247B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01200928 2001-03-12
PCT/EP2002/002459 WO2002072574A1 (en) 2001-03-12 2002-03-05 Process for the preparation of imidazole compounds

Publications (2)

Publication Number Publication Date
EE200300442A true EE200300442A (et) 2003-12-15
EE05247B1 EE05247B1 (et) 2009-12-15

Family

ID=8180004

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300442A EE05247B1 (et) 2001-03-12 2002-03-05 Meetod imidasoolhendite valmistamiseks

Country Status (31)

Country Link
US (1) US6844439B2 (et)
EP (1) EP1373255B1 (et)
JP (1) JP4257698B2 (et)
KR (1) KR100849042B1 (et)
CN (1) CN1246318C (et)
AR (1) AR035944A1 (et)
AT (1) ATE287882T1 (et)
AU (1) AU2002253101B2 (et)
BR (1) BRPI0208075B8 (et)
CA (1) CA2438421C (et)
CZ (1) CZ300622B6 (et)
DE (1) DE60202755T2 (et)
DK (1) DK1373255T3 (et)
EA (1) EA006770B1 (et)
EE (1) EE05247B1 (et)
ES (1) ES2236505T3 (et)
HR (1) HRP20030695B1 (et)
HU (1) HU230282B1 (et)
IL (2) IL157839A0 (et)
MX (1) MXPA03008205A (et)
MY (1) MY124838A (et)
NO (1) NO324954B1 (et)
NZ (1) NZ528620A (et)
PL (1) PL208238B1 (et)
PT (1) PT1373255E (et)
SI (1) SI1373255T1 (et)
SK (1) SK287807B6 (et)
TW (1) TWI249532B (et)
UA (1) UA74871C2 (et)
WO (1) WO2002072574A1 (et)
ZA (1) ZA200307117B (et)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ20032691A3 (en) 2001-03-12 2004-04-14 Avanir Pharmaceuticals Benzimidazole compounds for modulating ige and inhibiting cellular proliferation
TWI276631B (en) 2002-09-12 2007-03-21 Avanir Pharmaceuticals Phenyl-aza-benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
AU2003270426A1 (en) 2002-09-12 2004-04-30 Avanir Pharmaceuticals PHENYL-INDOLE COMPOUNDS FOR MODULATING IgE AND INHIBITING CELLULAR PROLIFERATION
JP2007538004A (ja) * 2004-03-18 2007-12-27 ザ ブライハム アンド ウイメンズ ホスピタル, インコーポレイテッド シヌクレイノパチーを治療する方法
ES2308486T3 (es) * 2004-05-03 2008-12-01 Janssen Pharmaceutica Nv Proceso de sintesis diastereoselectiva para la preparacion de compuestos de imidazol.
CN100567291C (zh) * 2004-05-03 2009-12-09 詹森药业有限公司 用6-溴-4-(3-氯苯基)-2-甲氧基喹啉进行的非对映选择性合成方法
EP1758885B1 (en) 2004-05-03 2008-06-18 Janssen Pharmaceutica N.V. Diastereoselective addition of lithiated n-methylimidazole on sulfinimines
WO2007075923A2 (en) 2005-12-23 2007-07-05 Link Medicine Corporation Treatment of synucleinopathies
WO2009151683A2 (en) * 2008-03-12 2009-12-17 Link Medicine Corporation Quinolinone farnesyl transferase inhibitors for the treatment of synucleinopathies and other indications
KR101044430B1 (ko) * 2009-09-25 2011-06-27 듀오백코리아 주식회사 요추받이를 포함하는 의자의 등 지지 장치
KR101107900B1 (ko) * 2009-10-21 2012-01-25 성용기업 주식회사 의자용 허리지지장치
RS62709B1 (sr) 2015-08-17 2022-01-31 Kura Oncology Inc Postupci za lečenje pacijenata obolelih od kancera pomoću inhibitora farneziltransferaze
PL3534885T3 (pl) 2016-11-03 2021-11-15 Kura Oncology, Inc. Inhibitory farnezylotransferazy do zastosowania w leczeniu nowotworu
CN110234639A (zh) * 2016-12-08 2019-09-13 杭州领业医药科技有限公司 替吡法尼的晶型及其制备方法及药物组合物
EP3793966A1 (en) 2018-05-18 2021-03-24 Kura Oncology, Inc. Synthesis of tipifarnib

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW349948B (en) 1995-10-31 1999-01-11 Janssen Pharmaceutica Nv Farnesyl transferase inhibiting 2-quinolone derivatives
BR9610745A (pt) * 1995-12-08 1999-07-13 Janssen Pharmaceutica Nv Derivados de (imidazol-5-il) metil-2-quinolinona inibindo a transferase da proteina farnesil
TW591030B (en) * 1997-03-10 2004-06-11 Janssen Pharmaceutica Nv Farnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with N- or C-linked imidazoles
NZ336233A (en) * 1997-04-25 2001-01-26 Janssen Pharmaceutica Nv Phenyl substituted quinazolines on 4-position and 2-quinazolinone moiety bearing a carbon or nitrogen-linked imidazolyl moiety
HUP0103228A3 (en) * 1998-08-27 2003-01-28 Pfizer Prod Inc Alkynyl-substituted quinolin-2-one derivatives useful as anticancer agents and pharmaceutical compositions containing them
WO2000012498A1 (en) 1998-08-27 2000-03-09 Pfizer Products Inc. Quinolin-2-one derivatives useful as anticancer agents

Also Published As

Publication number Publication date
IL157839A0 (en) 2004-03-28
IL157839A (en) 2008-07-08
CN1496363A (zh) 2004-05-12
CZ300622B6 (cs) 2009-07-01
SK287807B6 (sk) 2011-10-04
KR100849042B1 (ko) 2008-07-29
DK1373255T3 (da) 2005-05-23
ES2236505T3 (es) 2005-07-16
BRPI0208075B8 (pt) 2021-05-25
NO20034003D0 (no) 2003-09-10
UA74871C2 (en) 2006-02-15
NO324954B1 (no) 2008-01-14
EA006770B1 (ru) 2006-04-28
HU230282B1 (hu) 2015-12-28
DE60202755D1 (de) 2005-03-03
HRP20030695A2 (en) 2005-02-28
HUP0303443A3 (en) 2012-09-28
SK12462003A3 (sk) 2004-06-08
TWI249532B (en) 2006-02-21
AR035944A1 (es) 2004-07-28
HK1063315A1 (zh) 2004-12-24
MXPA03008205A (es) 2004-01-29
EA200300998A1 (ru) 2004-02-26
US20040138256A1 (en) 2004-07-15
CN1246318C (zh) 2006-03-22
WO2002072574A1 (en) 2002-09-19
MY124838A (en) 2006-07-31
CZ20032704A3 (en) 2004-03-17
NO20034003L (no) 2003-10-22
JP4257698B2 (ja) 2009-04-22
KR20030079971A (ko) 2003-10-10
EP1373255B1 (en) 2005-01-26
HRP20030695B1 (hr) 2011-07-31
EP1373255A1 (en) 2004-01-02
ZA200307117B (en) 2004-09-13
PT1373255E (pt) 2005-05-31
HUP0303443A2 (hu) 2004-01-28
JP2004523575A (ja) 2004-08-05
NZ528620A (en) 2005-01-28
CA2438421C (en) 2010-05-18
EE05247B1 (et) 2009-12-15
US6844439B2 (en) 2005-01-18
PL208238B1 (pl) 2011-04-29
PL363263A1 (en) 2004-11-15
ATE287882T1 (de) 2005-02-15
BRPI0208075B1 (pt) 2018-02-14
SI1373255T1 (et) 2005-08-31
CA2438421A1 (en) 2002-09-19
BR0208075A (pt) 2004-03-02
DE60202755T2 (de) 2006-03-30
AU2002253101B2 (en) 2007-08-09

Similar Documents

Publication Publication Date Title
NO20042680L (no) Fremgangsmater for fremstilling av O-demetylvenflaxine
NO20030012L (no) Fremgangsmåte for fremstilling av substituerte oktanoylamider
NO20040027L (no) Fremgangsmate for fremstillingen av escitalopram
FI20011541A0 (fi) Menetelmä massan valmistamiseksi
EE200300442A (et) Meetod imidasoolühendite valmistamiseks
NO20033433L (no) Fremgangsmåte for fremstilling av 2-(2-pyridylmetyl)sulfinyl- 1H-benzimidasol
NO20044814L (no) Fremgangsmate for fremstilling av combretastaniner
NO20035538D0 (no) Fremgangsmåte for fremstilling av zaleplon
NO20030515L (no) Fremgangsmåte for fremstilling av dinapsolin
FR2826002B1 (fr) Procede de preparation de composes bromodifluoroacetiques
NO20035586L (no) Fremgangsmate for fremstilling av cykloheksanol-derivater
NO20035136D0 (no) Fremgangsmåte til fremstilling av imipenem
NO20033147D0 (no) Fremgangsmate for fremstilling av rent ondansetronhydrogenkloriddihydrat
NO20024887L (no) FremgangsmÕte for fremstilling av benzokondenserte heterosykliske forbindelser
NO20023702D0 (no) Fremgangsmåte for fremstilling av 5-arylnikotinaldehyder
NO20035138D0 (no) Fremgangsmåte til fremstilling av amorft natriumsilastatin
NO20052396D0 (no) Fremgangsmate for fremstilling av spirolactonforbindelser
DK1565445T3 (da) Fremgangsmåde til fremstilling af imidazolylforbindelser
NO20013802D0 (no) Fremgangsmåte for fremstilling av kitosaner
NO20040149L (no) Fremgangsmåte for fremstilling av tagatose
ITMI20010771A0 (it) Processo per la preparazione di composti piridil-aril-solfonici
ITMI20010772A0 (it) Processo per la preparazione di composti aril-piridinici
FR2829492B1 (fr) Procede de preparation de la disorbitylamine
DK1274684T3 (da) Fremgangsmåde til fremstilling af aryl-pyridinylforbindelser
DK1280792T3 (da) Fremgangsmåde til fremstilling af benzo-annelerede heterocykler

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20101231